The Promise of the Ring (IMAGE)
Caption
This World AIDS Day, women have reason to be optimistic that a new era may be at hand - one in which they could have more choices to protect themselves against HIV.
Earlier this year, a novel monthly vaginal ring developed by the International Partnership for Microbicides became the first long-acting method to show efficacy in two Phase III clinical trials.
Watch this video to learn about the dapivirine ring and IPM's next steps to potentially put the discreet, self-initiated product into the hands of women at high risk for HIV.
Credit
copyright 2016 IPM
Usage Restrictions
None
License
Licensed content